lynda

2016 Pipeline of Anxiety Disorders Market Therapeutics Development

Press Release   •   May 02, 2016 07:37 EDT

In-detail Table of Contents of Anxiety Disorders Pipeline Market

Companies Involved in Therapeutics Development AbbVie Inc., Ache Laboratorios Farmaceuticos S/A, Adamed Sp. z o.o., Addex Therapeutics Ltd, Amorsa Therapeutics Inc., Avineuro Pharmaceuticals, Inc., Azevan Pharmaceuticals, Inc., Bionomics Limited, Boehringer Ingelheim GmbH, C4X Discovery Holdings PLC, Catalyst Pharmaceutical Partners, Inc., Edgemont Pharmaceuticals, LLC, Eisai Co., Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Gabather AB, GW Pharmaceuticals Plc, HolsboerMaschmeyer NeuroChemie GmbH, Humanetics Corporation, IntelGenx Corp., Intra-Cellular Therapies, Inc., INVENT Pharmaceuticals, Inc., Marinus Pharmaceuticals, Inc., Merz Pharma GmbH & Co. KgaA, MI.TO. Technology S.r.L., Nemus Bioscience, Inc., Neuralstem, Inc., Neurelis, Inc., NeuroNascent, Inc., Newron Pharmaceuticals S.p.A., Nippon Chemiphar Co., Ltd., Novartis AG, Omeros Corporation, Otsuka Holdings Co., Ltd., Pherin Pharmaceuticals, Inc., Polleo Pharma Limited, Protagenic Therapeutics Inc., Suda Ltd, Sumitomo Dainippon Pharma Co., Ltd., Synchroneuron Inc., Tonix Pharmaceuticals Holding Corp., Trevena, Inc., TRImaran Pharma, Inc., Turing Pharmaceuticals AG and Vanda Pharmaceuticals Inc.

Get discount on this research at http://www.rnrmarketresearch.com/contacts/discount?rname=538731 .

Scope for this research:

  • The report provides a snapshot of the global therapeutic landscape of Anxiety Disorders
  • The report reviews pipeline therapeutics for Anxiety Disorders by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved Anxiety Disorders therapeutics and enlists all their major and minor projects
  • The report assesses Anxiety Disorders therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Anxiety Disorders

The report provides comprehensive information on the therapeutics under development for Anxiety Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Anxiety Disorders and features dormant and discontinued projects.

Complete research report at http://www.rnrmarketresearch.com/anxiety-disorders-pipeline-review-h1-2016-market-report.html .

List of Figures:

  • Number of Products under Development for Anxiety Disorders, H1 2016
  • Number of Products under Development for Anxiety Disorders - Comparative Analysis, H1 2016
  • Number of Products under Development by Companies, H1 2016
  • Number of Products under Investigation by Universities/Institutes, H1 2016
  • Comparative Analysis by Clinical Stage Development, H1 2016
  • Comparative Analysis by Early Stage Products, H1 2016
  • Assessment by Monotherapy Products, H1 2016
  • Number of Products by Top 10 Targets, H1 2016
  • Number of Products by Stage and Top 10 Targets, H1 2016
  • Number of Products by Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016
  • Number of Products by Routes of Administration, H1 2016
  • Number of Products by Stage and Routes of Administration, H1 2016
  • Number of Products by Molecule Types, H1 2016
  • Number of Products by Stage and Molecule Types, H1 2016

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.